Intercept Pharma (ICPT) Granted Accelerated Approval to Ocaliva in PBC - StreetInsider.com

Xconomy

Intercept Pharma (ICPT) Granted Accelerated Approval to Ocaliva in PBC StreetInsider.com News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. Late Friday, Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) announced that the U.S. Food and Drug Administration (FDA) has ... Intercept's (ICPT) Liver Dug Ocaliva Approved by the FDAZacks.com FDA Grants Accelerated Approval to Ocaliva™ (Obeticholic Acid) for the Treatment of Patients with PBCForexTV.com Intercept Wins FDA Approval for Drug to Treat Liver DiseaseBloomberg Xconomy -Mid-Day Daily -FierceBiotech -ValueWalk all 17 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNF4jkTMSv0H0gNMQX1swN4voUyTig&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779120879330&ei=nrFMV-jNPMiB3wGQsoGwBg&url=http://www.streetinsider.com/Corporate%2BNews/Intercept%2BPharma%2B(ICPT)%2BGranted%2BAccelerated%2BApproval%2Bto%2BOcaliva%2Bin%2BPBC/11687111.html
via IFTTT